Diaceutics PLC Attending 10th Annual HealthTech Investment Forum
September 07 2023 - 2:00AM
RNS Non-Regulatory
TIDMDXRX
Diaceutics PLC
07 September 2023
Diaceutics to attend 10(th) Annual HealthTech Investment Forum
in Basel on September 19
Belfast and London, 7 September 2023 - Diaceutics PLC (AIM:
DXRX) , a leading technology and solutions provider to the
pharmaceutical industry, announces that management will attend and
present at the 10 (th) Annual HealthTech Investment Forum in Basel,
Switzerland on 19 September, 2023. Diaceutics CEO Peter Keeling
will be a
speaker at the Revolution in Precision Medicine Panel: Investing in Big Data & AI .
For more information, please click here .
Enquiries:
Diaceutics PLC Tel: +44 (0)28 9040 6500
Peter Keeling, Chief Executive Officer investorrelations@diaceutics.com
Ryan Keeling, Chief Innovation Officer
Nick Roberts, Chief Financial Officer
Stifel Nicolaus Europe Limited (Nomad Tel: +44 (0)20 7710 7600
& Broker)
Ben Maddison
Nick Harland
Kate Hanshaw
Alma PR Tel: +44 (0)20 3405 0205
Caroline Forde diaceutics@almapr.co.uk
Matthew Young
Kinvara Verdon
About Diaceutics
At Diaceutics we believe that every patient should get the
opportunity to receive the right test and the right therapy to
positively impact their disease outcome.
We provide the world's leading pharma and biotech companies with
an end-to-end commercialization solution for precision medicines
through data analytics, scientific and advisory services enabled by
our platform DXRX - The Diagnostic Network(R).
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAFLFFEALIEIIV
(END) Dow Jones Newswires
September 07, 2023 02:00 ET (06:00 GMT)
Diaceutics (LSE:DXRX)
Historical Stock Chart
From May 2024 to Jun 2024
Diaceutics (LSE:DXRX)
Historical Stock Chart
From Jun 2023 to Jun 2024